ANNALS OF THE RHEUMATIC DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2015-03-04 medcardio

已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表::
审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。

匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。

459 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2014-12-11 匿名用户

审稿速度:3.0
经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。

393 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2014-07-28 匿名用户

此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒

477 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2014-06-03 匿名用户

各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。

481 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2013-07-16 homosapiens

风湿类权威杂志，超级难啊

527 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2013-01-20 JamesHuang

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......

510 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2013-01-18 匿名用户

没有送外审直接被拒，建议转投免疫学领域。

498 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2012-11-08 clearhui

将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？

514 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2012-11-01 clearhui

审稿速度:1.0
经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……

574 0

[GetPortalCommentsPageByObjectIdResponse(id=510231, encodeId=bda051023144, content=已经超快了，顶尖刊物，稿量大，这么快速度不易！不过祝贺你，发这么高分匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=匿名 2014-12-11 发表:: 审稿时间：约3个月 6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Mar 04 19:04:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508351, encodeId=5e6e5083517e, content=审稿速度:3.0 经验分享：6月投稿，一审2月，3个reviewers，但修会后又等了近2个月，再次小修，修回后一周后接收。总之杂志要求严格，评审很有水准，就是耗时有点长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Dec 11 11:07:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504362, encodeId=de3e50436241, content=此杂志我发表过一篇著述，审稿很快，但要求极高，评审很严，要求一流水平，投前一定对自己内容很有把握才考虑，不然可能进不了外审就拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=477, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 28 12:09:00 CST 2014, time=2014-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503293, encodeId=519f503293d9, content=各位兄弟姐妹请问annals of the rheumatic diseases你们参考文献用endnote的哪个格式编辑的，我始终没有找到合适的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=481, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 03 07:07:00 CST 2014, time=2014-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497924, encodeId=c88f49e92405, content=风湿类权威杂志，超级难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=277f84425, createdName=homosapiens, createdTime=Tue Jul 16 16:13:00 CST 2013, time=2013-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493509, encodeId=202f4935092b, content=没有送外审直接被拒，建议转投免疫学领域。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jan 18 08:58:00 CST 2013, time=2013-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491406, encodeId=78d9491406d9, content=将近10天过去了，状态还是副主编决定，这个杂志这个阶段要经历多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 08 20:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491312, encodeId=16844913126e, content=审稿速度:1.0 经验分享：10月1日投出去，不到一周就进入同行评议阶段，10月31日转入AE decision，就要揭晓答案了，等待中，期待好运……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db9270537, createdName=clearhui, createdTime=Thu Nov 01 16:53:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491103, encodeId=e8f2491103f9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：命中率15%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=496, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 20 09:31:00 CST 2012, time=2012-10-20, status=1, ipAttribution=)]

2012-10-20 匿名用户

审稿速度:1.0 | 投稿命中率:25.0
经验分享：命中率15%。

496 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务